Skip to main content
. 2020 Oct 15;11(12):2433–2440. doi: 10.1021/acsmedchemlett.0c00416

Table 4. Antibacterial Activity of Selected Compounds.

  MIC (μM)a
Cmpd E. coli (ATCC 25922) S. aureus (ATCC 29213) E. faecalis (ATCC 29212) P. aeruginosa (ATCC 27853) E. coli (JD17464)b E. coli (JW5503)c
4a, 4b, 5a, 5b, 9a, 9c, 10, 14, 15c, 15d >50 μM >50 μM >50 μM >50 μM >50 μM >50 μM
9b >50 μM >50 μM >50 μM >50 μM >50 μM 1.56 μM
13 >50 μM >50 μM >50 μM >50 μM >50 μM 50 μM
15a >50 μM >50 μM 3.13 μM >50 μM >50 μM 0.78 μM
15b >50 μM >50 μM >50 μM >50 μM >50 μM 1.56 μM
15e >50 μM >50 μM 3.13 μM >50 μM >50 μM 0.78 μM
16a >50 μM >50 μM 12.5 μM. >50 μM >50 μM 12.5 μM
16b >50 μM 25 μM 6.25 μM >50 μM >50 μM 3.13 μM
ciprofloxacin 0.05 μM 1.51 μM 3.02 μM 3.02 μM 0.121 μM 0.015 μM
a

MIC (minimum inhibitory concentration that inhibits the growth of bacteria by ≥90%) values against E. coli and S. aureus.

b

E. coli strain with impaired outer membrane, lpxC deletion mutant.

c

E. coli strain with defective efflux pump, tolC deletion mutant.